Dr. Cameron Lind Budenz, MD

Dr. Budenz practices at ENT and Allergy Associates in Tarrytown, New York.

Dr. Budenz's NPI, 1679609465, was assigned on February 26, 2007. Dr. Budenz graduated from University Of Michigan Medical School in 2005. Dr. Budenz's New York license number on file is 249251.

Dr. Budenz's primary practice is ENT and Allergy Associates, at 200 White Plains Rd, Tarrytown, NY 10591 in Westchester County. The practice phone is (914) 333-5800.

Dr. Budenz's primary practice is ENT and Allergy Associates in Tarrytown, New York. Dr. Budenz is also affiliated with Vassar Brothers Medical Center. The medical group on file is ENT and Allergy Associates. Dmand AI also links Dr. Budenz to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Budenz practices, 5 sites in all. Vendor and product names are available with a free account.

Otology and neurotology is Dr. Budenz's primary specialty in the NPI Registry, under taxonomy code 207YX0901X. Dr. Budenz is board certified in neurotology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Budenz's licenses on file in 2 states: New York and Michigan.

Dmand AI lists chronic ear infection, ear eustachian tube disorders, ear infection, hearing loss and impairment, swimmer's ear, tinnitus, upper respiratory infection (URI) and vertigo among the conditions Dr. Budenz treats.

CMS data shows 1,979 Medicare services from Dr. Budenz across 13 procedure codes in 2024, for 684 Medicare patients. Medicare paid $137,350 for them.

CMS counts 684 Medicare patients who saw Dr. Budenz in 2024. The largest group is 65 to 74, with 281 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Budenz's median patient age at 63, with 56% women.

In 2024, Dr. Budenz wrote 354 Medicare Part D claims for 145 patients. 77% of them were for generic drugs. CMS names the drug for 275 of them, across 8 drugs with 11 or more claims each, at $13,269 in total drug cost. In 2023, CMS named 287 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Budenz for performance year 2024, reported as part of a group. Dr. Budenz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Budenz, published from 2005 to 2014. The most frequent topics are Cochlear Implants, Cochlear Implantation and Speech Perception. Dr. Budenz has published most often in Otol Neurotol. Dr. Budenz's most frequent co-authors are Peter C. Baxter, MD, Daniel H. Coelho, MD and Maura K. Cosetti, MD.

CMS Open Payments shows 176 general payments to Dr. Budenz from 37 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Optinose US, Inc. paid the most, $617.

Dr. Budenz graduated from University Of Michigan Medical School in 2005. Dr. Budenz is a member of NHS, AMA and American Neurotology Society.

Dr. Budenz is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and MVP Health Care. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.